Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts

Autor: Thompson, H.S.G ^a, Davies, M.L ^a, Holding, F.P ^a, Fallon, R.E ^a, Mann, A.E ^a, O'Neill, T ^a, St Clair Roberts, J ^{a, *}

Publikováno v: In Vaccine 1999 17(1):40-49

A comprehensive evaluation of dermal fibroblast therapy in clinical trials for treating skin disorders and cosmetic applications: a scoping review.

Autor: Rahnama, Maryam^1,2 (AUTHOR), Ghasemzadeh, Navid^1,3 (AUTHOR), Ebrahimi, Yaser^1,3 (AUTHOR), Golchin, Ali^1,2,4 (AUTHOR) agolchin.vet10@yahoo.com

Publikováno v: Stem Cell Research & Therapy. 9/20/2024, Vol. 15 Issue 1, p1-19. 19p.

A phase IIa open-label dose-escalation pilot study using allogeneic human dermal fibroblasts for nasolabial folds.

Autor: Lowe NJ; Department of Dermatology, School of Medicine, University of California at Los Angeles, Los Angeles, California, USA. cranley@cranleyclinic.com, Lowe PL, St Clair Roberts J

Publikováno v: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] [Dermatol Surg] 2010 Oct; Vol. 36 (10), pp. 1578-85. Date of Electronic Publication: 2010 Aug 16.

Experience with Vi typhoid capsular polysaccharide vaccine in the U.K.

Autor: Arnold WS; Mérieux U.K. Ltd, Maidenhead, Berkshire, U.K., Harcus AW, St Clair Roberts J, Ward AE

Publikováno v: The Journal of infection [J Infect] 1992 Jul; Vol. 25 (1), pp. 63-6.

The Interaction of Human Papillomavirus Infection and Prostaglandin E 2 Signaling in Carcinogenesis: A Focus on Cervical Cancer Therapeutics.

Autor: García-Quiroz, Janice¹ (AUTHOR), Vázquez-Almazán, Bismarck¹ (AUTHOR), García-Becerra, Rocío² (AUTHOR), Díaz, Lorenza¹ (AUTHOR), Avila, Euclides¹ (AUTHOR) euclides.avilac@incmnsz.mx

Publikováno v: Cells (2073-4409). Aug2022, Vol. 11 Issue 16, p2528. 32p.